CLINICAL_TRIALS
trial_result
· 2020-06-11
Clinical Trial Update: Fibroblast Growth Factor Regeneration of Tympanic Membrane Perforations [Phase 2]
Summary
Phase 2 clinical trial evaluating fibroblast growth factor for regeneration of tympanic membrane perforations has completed. Results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: D. Bradley Welling, MD, PhD | Conditions: Tympanic Membrane Perforation | Phase 2 | Status: COMPLETED | Results posted: 2020-06-11